Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.
Stocks · News reference
8-K filing — SANGAMO THERAPEUTICS, INC (SGMO)
Filed: 2026-06-23 AccNo: 0001193125-26-278582 Size: 169 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 2.05: Cost Associated with Exit or Disposal Activities
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sangamo Therapeutics Files For Chapter 11 Bankruptcy, Secures Up To $30M In Debtor-In-Possession Financing; Launches Court-Supervised Asset Sale Process With Eli Lilly And Astellas As Stalking Horse Bidders For Key Gene Therapy, Genome Editing, And Fabry Disease Assets; Expects Restructuring To Result In Elimination Of About 51 Roles In U.S., Or About 40% Of Company's Workforce
Deal Dispatch: Carlyle Buys Chung Ho Group, Second Nature Brands Acquires Tillamook Country Smoker, GoHealth Bankruptcy
Multiple M&A transactions and bankruptcies reported: Carlyle Group acquired South Korean home appliance rental platform Chung Ho Group for $700 million; Second Nature Brands acquired Tillamook Country Smoker; GoHealth filed for Chapter 11 bankruptcy; Sleep Number agreed to merge with Sleep Country Canada after filing for bankruptcy; and several other companies announced strategic reviews or acquisitions.